Lupus nephritis: An overview of recent findings

Autoimmune Diseases

Volumn 1, Issue 1, 2012, Pages

  De Zubiria Salgado, Alberto ^a,b   Herrera Diaz, Catalina ^b  

^a University Hospital   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; AZATHIOPRINE; BELIMUMAB; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; EPITOPE; HLA DRB1 ANTIGEN; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 10; INTERLEUKIN 4; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; OX40 LIGAND; PLACEBO; PREDNISOLONE; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN; PROTEIN ITGAM; PROTEIN KINASE TYK2; PROTEIN TNFAIP3; PROTEINASE; RITUXIMAB; SECURIN; STAT4 PROTEIN; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ALPHA ACTININ; GAMMA INTERFERON; HEPARAN SULFATE; HLA DQ ANTIGEN; HLA DR2 ANTIGEN; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; LAMININ; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; STEROID; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ABSENCE OF SIDE EFFECTS; ADAPTIVE IMMUNITY; APOPTOSIS; CELL PROLIFERATION; COMPLEMENT SYSTEM; CYTOKINE RELEASE; DENDRITIC CELL; DRUG DOSE REDUCTION; DRUG MEGADOSE; ENDOTHELIUM INJURY; ENZYME RELEASE; EPITHELIUM CELL; ETHNICITY; EXPERIMENTAL MODEL; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFLAMMATION; KIDNEY EPITHELIUM; KIDNEY FAILURE; KIDNEY FIBROSIS; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MAINTENANCE THERAPY; MESANGIUM CELL; MONOCYTE; MULTICENTER STUDY (TOPIC); NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; TREATMENT OUTCOME; AFRICA; AUTOIMMUNITY; B LYMPHOCYTE; CAUCASIAN; CELL ACTIVATION; CELL ADHESION; CELL INFILTRATION; CELL MATURATION; GENE EXPRESSION; GENETIC ASSOCIATION; HAPLOTYPE; HISPANIC; INTERSTITIAL NEPHRITIS; MACROPHAGE; MISSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHAGOCYTE; TH3 CELL; UNSPECIFIED SIDE EFFECT;

EID: 84872509495     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2012/849684     Document Type: Review

References (199)

1. Ortega L. M., Schultz D. R., Lenz O., Pardo V., Contreras G. N., Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions Lupus 2010 19 5 557 574
2. Mok C. C., Biomarkers for lupus nephritis: a critical appraisal Journal of Biomedicine and Biotechnology 2010 2010 11
3. Anaya J.-M., Caas C., Mantilla R. D., Pineda-Tamayo R., Tobn G. J., Herrera-Diaz C., Rendn D. M., Rojas-Villarraga A., Uribe M., Lupus nephritis in colombians: contrasts and comparisons with other populations Clinical Reviews in Allergy and Immunology 2011 40 3 199 207
4. Varela D. C., Quintana G., Somers E. C., Rojas-Villarraga A., Espinosa G., Hincapie M. E., McCune W. J., Cervera R., Anaya J. M., Delayed lupus nephritis Annals of the Rheumatic Diseases 2008 67 7 1044 1046 (Pubitemid 351956673)
5. Lewis E. J., Schwartz M. M., Pathology of lupus nephritis Lupus 2005 14 1 31 38 (Pubitemid 40216065)
6. Contreras G., Lenz O., Pardo V., Borja E., Cely C., Iqbal K., Nahar N., De La Cuesta C., Hurtado A., Fornoni A., Beltran-Garcia L., Asif A., Young L., Diego J., Zachariah M., Smith-Norwood B., Outcomes in African Americans and Hispanics with lupus nephritis Kidney International 2006 69 10 1846 1851 (Pubitemid 43739214)
7. Molina J. F., Molina J., Garca C., Gharavi A. E., Wilson W. A., Espinoza L. R., Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans Lupus 1997 6 1 63 67 (Pubitemid 27055737)
8. Pons-Estel B. A., Catoggio L. J., Cardiel M. H., Soriano E. R., Gentiletti S., Villa A. R., Abadi I., Caeiro F., Alvarellos A., Alarcn-Segovia D., The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among Hispanics Medicine 2004 83 1 1 17 (Pubitemid 38124852)
9. Peutz-Kootstra C. J., de Heer E., Hoedemaeker P. J., Abrass C. K., Bruijn J. A., Lupus nephritis: lessons from experimental animal models Journal of Laboratory and Clinical Medicine 2001 137 4 244 260 (Pubitemid 32296062)
10. Hicks J., Bullard D. C., Review of autoimmune (lupus-like) glomerulonephritis in murine models Ultrastructural Pathology 2006 30 5 345 359 (Pubitemid 44721669)
11. Tsao B. P., Ohnishi K., Cheroutre H., Mitchell B., Teitell M., Mixter P., Kronenberg M., Hahn B. H., Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice Journal of Immunology 1992 149 1 350 358
12. Clynes R., Dumitru C., Ravetch J. V., Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis Science 1998 279 5353 1052 1054 (Pubitemid 28113310)
13. Deshmukh U. S., Bagavant H., Fu S. M., Role of anti-DNA antibodies in the pathogenesis of lupus nephritis Autoimmunity Reviews 2006 5 6 414 418 (Pubitemid 44143035)
14. Coritsidis G. N., Lombardo F., Rumore P., Kuo S. F., Izzo R., Mir R., Beers P., Nucleosome effects on mesangial cell matrix and proliferation: a possible role in early lupus nephritis Experimental Nephrology 2002 10 3 216 226 (Pubitemid 34621599)
15. Lucas J. A., Menke J., Rabacal W. A., Schoen F. J., Sharpe A. H., Kelley V. R., Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice Journal of Immunology 2008 181 4 2513 2521
16. Odegard J. M., DiPlacido L. D., Greenwald L., Kashgarian M., Kono D. H., Dong C., Flavell R. A., Craft J., ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus Journal of Immunology 2009 182 7 4076 4084
17. Francisco L. M., Sage P. T., Sharpe A. H., The PD-1 pathway in tolerance and autoimmunity Immunological Reviews 2010 236 1 219 242
18. Kanta H., Mohan C., Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation Genes and Immunity 2009 10 5 390 396
19. Wardemann H., Yurasov S., Schaefer A., Young J. W., Meffre E., Nussenzweig M. C., Predominant autoantibody production by early human B cell precursors Science 2003 301 5638 1374 1377 (Pubitemid 37075812)
20. Jacobi A. M., Diamond B., Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus Journal of Experimental Medicine 2005 202 3 341 344 (Pubitemid 41126950)
21. Michaels M. A., Kang H. K., Kaliyaperumal A., Satyaraj E., Shi Y., Datta S. K., A defect in deletion of nucleosome-specific autoimmune T cells in lupus-prone thymus: role of thymic dendritic cells Journal of Immunology 2005 175 9 5857 5865 (Pubitemid 41508070)
22. Erikson J., Mandik L., Bui A., Eaton A., Noorchashm H., Nguyen K. A. T., Roark J. H., Self-reactive B cells in nonautoimmune and autoimmune mice Immunologic Research 1998 17 1-2 49 61 (Pubitemid 28072394)
23. Harley J. B., Alarcn-Riquelme M. E., Criswell L. A., Jacob C. O., Kimberly R. P., Moser K. L., Tsao B. P., Vyse T. J., Langefeld C. D., Nath S. K., Guthridge J. M., Cobb B. L., Mirel D. B., Marion M. C., Williams A. H., Divers J., Wang W., Frank S. G., Namjou B., Gabriel S. B., Lee A. T., Gregersen P. K., Behrens T. W., Taylor K. E., Fernando M., Zidovetzki R., Gaffney P. M., Edberg J. C., Rioux J. D., Ojwang J. O., James J. A., Merrill J. T., Gilkeson G. S., Seldin M. F., Yin H., Baechler E. C., Li Q. Z., Wakeland E. K., Bruner G. R., Kaufman K. M., Kelly J. A., Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci Nature Genetics 2008 40 2 204 210 (Pubitemid 351171405)
24. Gregersen P. K., Lee H. S., Batliwalla F., Begovich A. B., PTPN22: setting thresholds for autoimmunity Seminars in Immunology 2006 18 4 214 223 (Pubitemid 43903284)
25. Arechiga A. F., Habib T., He Y., Zhang X., Zhang Z. Y., Funk A., Buckner J. H., Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling Journal of Immunology 2009 182 6 3343 3347
26. Banchereau J., Pascual V., Type I interferon in systemic lupus erythematosus and other autoimmune diseases Immunity 2006 25 3 383 392 (Pubitemid 44354221)
27. Surolia I., Pirnie S. P., Chellappa V., Taylor K. N., Cariappa A., Moya J., Liu H., Bell D. W., Driscoll D. R., Diederichs S., Haider K., Netravali I., Le S., Elia R., Dow E., Lee A., Freudenberg J., De Jager P. L., Chretien Y., Varki A., MacDonald M. E., Gillis T., Behrens T. W., Bloch D., Collier D., Korzenik J., Podolsky D. K., Hafler D., Murali M., Sands B., Stone J. H., Gregersen P. K., Pillai S., Functionally defective germline variants of sialic acid acetylesterase in autoimmunity Nature 2010 466 7303 243 247
28. Fronek Z., Timmerman L. A., Alper C. A., Hahn B. H., Kalunian K., Peterlin B. M., McDevitt H. O., Major histocompatibility complex associations with systemic lupus erythematosus American Journal of Medicine 1988 85 6 42 44 (Pubitemid 19020565)
29. Fronek Z., Timmerman L. A., Alper C. A., Hahn B. H., Kalunian K., Peterlin B. M., McDevitt H. O., Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus Arthritis and Rheumatism 1990 33 10 1542 1553 (Pubitemid 20362098)
30. Kim-Howard X., Maiti A. K., Anaya J. M., Bruner G. R., Brown E., Merrill J. T., Edberg J. C., Petri M. A., Reveille J. D., Ramsey-Goldman R., Alarcon G. S., Vyse T. J., Gilkeson G., Kimberly R. P., James J. A., Guthridge J. M., Harley J. B., Nath S. K., ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry Annals of the Rheumatic Diseases 2010 69 7 1329 1332
31. Salmon J. E., Millard S., Schachter L. A., Arnett F. C., Ginzler E. M., Gourley M. F., Ramsey-Goldman R., Peterson M. G. E., Kimberly R. P., Fc RIIA alleles are heritable risk factors for lupus nephritis in African Americans The Journal of Clinical Investigation 1996 97 5 1348 1354 (Pubitemid 26085492)
32. Delgado-Vega A., Snchez E., Lfgren S., Castillejo-Lpez C., Alarcn-Riquelme M. E., Recent findings on genetics of systemic autoimmune diseases Current Opinion in Immunology 2010 22 6 698 705
33. Ramos P. S., Brown E. E., Kimberly R. P., Langefeld C. D., Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis Seminars in Nephrology 2010 30 2 164 176
34. Fernando M. M., Stevens C. R., Sabeti P. C., Walsh E. C., McWhinnie A. J., Shah A., Green T., Rioux J. D., Vyse T. J., Identification of two independent risk factors for lupus within the MHC in United Kingdom families PLoS Genetics 2007 3 11, article e192
35. Rioux J. D., Goyette P., Vyse T. J., Hammarstrm L., Fernando M. M. A., Green T., De Jager P. L., Foisy S., Wang J., De Bakker P. I. W., Leslie S., McVean G., Padyukov L., Alfredsson L., Annese V., Hafler D. A., Pan-Hammarstrm Q., Matell R., Sawcer S. J., Compston A. D., Cree B. A. C., Mirel D. B., Daly M. J., Behrens T. W., Klareskog L., Gregersen P. K., Oksenberg J. R., Hauser S. L., Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases Proceedings of the National Academy of Sciences of the United States of America 2009 106 44 18680 18685
36. Ruiz-Narvaez E. A., Fraser P. A., Palmer J. R., Cupples L. A., Reich D., Wang Y. A., Rioux J. D., Rosenberg L., MHC region and risk of systemic lupus erythematosus in African American women Human Genetics 2011 130 6 807 815
37. Castao-Rodrguez N., Diaz-Gallo L. M., Pineda-Tamayo R., Rojas-Villarraga A., Anaya J. M., Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus Autoimmunity Reviews 2008 7 4 322 330
38. Han J. W., Zheng H. F., Cui Y., Sun L. D., Ye D. Q., Hu Z., Xu J. H., Cai Z. M., Huang W., Zhao G. P., Xie H. F., Fang H., Lu Q. J., Xu J. H., Li X. P., Pan Y. F., Deng D. Q., Zeng F. Q., Ye Z. Z., Zhang X. Y., Wang Q. W., Hao F., Ma L., Zuo X. B., Zhou F. S., Du W. H., Cheng Y. L., Yang J. Q., Shen S. K., Li J., Sheng Y. J., Zuo X. X., Zhu W. F., Gao F., Zhang P. L., Guo Q., Li B., Gao M., Xiao F. L., Quan C., Zhang C., Zhang Z., Zhu K. J., Li Y., Hu D. Y., Lu W. S., Huang J. L., Liu S. X., Li H., Ren Y. Q., Wang Z. X., Yang C. J., Wang P. G., Zhou W. M., Lv Y. M., Zhang A. P., Zhang S. Q., Lin D., Li Y., Low H. Q., Shen M., Zhai Z. F., Wang Y., Zhang F. Y., Yang S., Liu J. J., Zhang X. J., Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus Nature Genetics 2009 41 11 1234 1237
39. Hom G., Graham R. R., Modrek B., Taylor K. E., Ortmann W., Garnier S., Lee A. T., Chung S. A., Ferreira R. C., Pant P. V. K., Ballinger D. G., Kosoy R., Demirci F. Y., Kamboh M. I., Kao A. H., Tian C., Gunnarsson I., Bengtsson A. A., Rantap-Dahlqvist S., Petri M., Manzi S., Seldin M. F., Rnnblom L., Syvnen A. C., Criswell L. A., Gregersen P. K., Behrens T. W., Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX The New England Journal of Medicine 2008 358 9 900 909 (Pubitemid 351397089)
40. Gateva V., Sandling J. K., Hom G., Taylor K. E., Chung S. A., Sun X., Ortmann W., Kosoy R., Ferreira R. C., Nordmark G., Gunnarsson I., Svenungsson E., Padyukov L., Sturfelt G., Jnsen A., Bengtsson A. A., Rantap-Dahlqvist S., Baechler E. C., Brown E. E., Alarcn G. S., Edberg J. C., Ramsey-Goldman R., McGwin G., Reveille J. D., Vil L. M., Kimberly R. P., Manzi S., Petri M. A., Lee A., Gregersen P. K., Seldin M. F., Rnnblom L., Criswell L. A., Syvnen A. C., Behrens T. W., Graham R. R., A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus Nature Genetics 2009 41 11 1228 1233
41. Hu W., Ren H., A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus International Journal of Immunogenetics 2011 38 5 411 417
42. Hellquist A., Jrvinen T. M., Koskenmies S., Zucchelli M., Orsmark-Pietras C., Berglind L., Panelius J., Hasan T., Julkunen H., D'Amato M., Saarialho-Kere U., Kere J., Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus Journal of Rheumatology 2009 36 8 1631 1638
43. Luan H., Li P., Cao C., Li C., Hu C., Zhang S., Zeng X., Zhang F., Zeng C., Li Y., A single-nucleotide polymorphism of the STAT4 gene is associated with systemic lupus erythematosus (SLE) in female Chinese population. Rheumatology International. In press
44. Li P., Cao C., Luan H., Li C., Hu C., Zhang S., Zeng X., Zhang F., Zeng C., Li Y., Association of genetic variations in the STAT4 and IRF7/KIAA1542 regions with systemic lupus erythematosus in a Northern Han Chinese population Human Immunology 2011 72 3 249 255
45. Graham R. R., Cotsapas C., Davies L., Hackett R., Lessard C. J., Leon J. M., Burtt N. P., Guiducci C., Parkin M., Gates C., Plenge R. M., Behrens T. W., Wither J. E., Rioux J. D., Fortin P. R., Cunninghame Graham D., Wong A. K., Vyse T. J., Daly M. J., Altshuler D., Moser K. L., Gaffney P. M., Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus Nature Genetics 2008 40 9 1059 1061
46. Yang W., Shen N., Ye D. Q., Liu Q., Zhang Y., Qian X. X., Hirankarn N., Ying D., Pan H. F., Mok C. C., Chan T. M., Wong R. W. S., Lee K. W., Mok M. Y., Wong S. N., Leung A. M. H., Li X. P., Avihingsanon Y., Wong C. M., Lee T. L., Ho M. H. K., Lee P. P. W., Chang Y. K., Li P. H., Li R. J., Zhang L., Wong W. H. S., Ng I. O. L., Lau C. S., Sham P. C., Lau Y. L., Genome-wide association study in asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus PLoS Genetics 2010 6 2
47. Musone S. L., Taylor K. E., Lu T. T., Nititham J., Ferreira R. C., Ortmann W., Shifrin N., Petri M. A., Ilyas Kamboh M., Manzi S., Seldin M. F., Gregersen P. K., Behrens T. W., Ma A., Kwok P. Y., Criswell L. A., Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus Nature Genetics 2008 40 9 1062 1064
48. Fan Y., Tao J.-H., Zhang L.-P., Li L.-H., Ye D.-Q., The association between BANK1 and TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis International Journal of Immunogenetics 2011 38 2 151 159
49. Nath S. K., Han S., Kim-Howard X., Kelly J. A., Viswanathan P., Gilkeson G. S., Chen W., Zhu C., McEver R. P., Kimberly R. P., Alarcn-Riquelme M. E., Vyse T. J., Li Q. Z., Wakeland E. K., Merrill J. T., James J. A., Kaufman K. M., Guthridge J. M., Harley J. B., A nonsynonymous functional variant in integrin- M (encoded by ITGAM) is associated with systemic lupus erythematosus Nature Genetics 2008 40 2 152 154 (Pubitemid 351171399)
50. Fan Y., Li L.-H., Pan H.-F., Tao J.-H., Sun Z.-Q., Ye D.-Q., Association of ITGAM polymorphism with systemic lupus erythematosus: a meta-analysis Journal of the European Academy of Dermatology and Venereology 2011 25 3 271 275
51. Kozyrev S. V., Abelson A. K., Wojcik J., Zaghlool A., Linga Reddy M. V. P., Sanchez E., Gunnarsson I., Svenungsson E., Sturfelt G., Jnsen A., Truedsson L., Pons-Estel B. A., Witte T., D'Alfonso S., Barrizzone N., Danieli M. G., Gutierrez C., Suarez A., Junker P., Laustrup H., Gonzlez-Escribano M. F., Martin J., Abderrahim H., Alarcn-Riquelme M. E., Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus Nature Genetics 2008 40 2 211 216 (Pubitemid 351171404)
52. Chang Y. K., Yang W., Zhao M., Mok C. C., Chan T. M., Wong R. W. S., Lee K. W., Mok M. Y., Wong S. N., Ng I. O. L., Lee T. L., Ho M. H. K., Lee P. P. W., Wong W. H. S., Lau C. S., Sham P. C., Lau Y. L., Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese Genes and Immunity 2009 10 5 414 420
53. Budarf M. L., Goyette P., Boucher G., Lian J., Graham R. R., Claudio J. O., Hudson T., Gladman D., Clarke A. E., Pope J. E., Peschken C., Smith C. D., Hanly J., Rich E., Boire G., Barr S. G., Zummer M., Fortin P. R., Wither J., Rioux J. D., A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles Genes and Immunity 2010 12 51 58
54. Lea W. W., Lee Y. H., The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update Lupus 2011 20 1 51 57
55. Ito I., Kawasaki A., Ito S., Hayashi T., Goto D., Matsumoto I., Tsutsumi A., Hom G., Graham R. R., Takasaki Y., Hashimoto H., Ohashi J., Behrens T. W., Sumida T., Tsuchiya N., Replication of the association between the C8orf13-BLK region and systemic lupus erythematosus in a Japanese population Arthritis and Rheumatism 2009 60 2 553 558
56. Fan Y., Tao J. H., Zhang L. P., Li L. H., Ye D. Q., Association of BLK (rs13277113, rs2248932) polymorphism with systemic lupus erythematosus: a meta-analysis Molecular Biology Reports 2010 38 4445 4453
57. Liu J.-L., Zhang F.-Y., Liang Y.-H., Xiao F.-L., Zhang S.-Q., Cheng Y.-L., Yuan C.-D., Chen Q.-P., Yang S., Zhang X.-J., Association between the PD1.3A/G polymorphism of the PDCD1 gene and systemic lupus erythematosus in European populations: a meta-analysis Journal of the European Academy of Dermatology and Venereology 2009 23 4 425 432
58. Graham D. S. C., Graham R. R., Manku H., Wong A. K., Whittaker J. C., Gaffney P. M., Moser K. L., Rioux J. D., Altshuler D., Behrens T. W., Vyse T. J., Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus Nature Genetics 2008 40 1 83 89
59. Lfgren S. E., Delgado-Vega A. M., Gallant C. J., Snchez E., Truedsson L., De Ramn Garrido E., Sabio J. M., Gonzlez-Escribano M. F., Pons-Estel B. A., D'Alfonso S., Witte T., Lauwerys B. R., Endreffy E., Kovcs L., Vasconcelos C., Martins Da Silva B., Martn J., Alarcn-Riquelme M. E., Kozyrev S. V., A 3′-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus Arthritis and Rheumatism 2010 62 11 3404 3414
60. Du Y., Tian L., Shen L. X., Wang F., Yu L. K., Song Y., Zhu J. F., Du R., Association of the CD226 single nucleotide polymorphism with systemic lupus erythematosus in the Chinese Han population Tissue Antigens 2011 77 1 65 67
61. Lee-Kirsch M. A., Gong M., Chowdhury D., Senenko L., Engel K., Lee Y. A., De Silva U., Bailey S. L., Witte T., Vyse T. J., Kere J., Pfeiffer C., Harvey S., Wong A., Koskenmies S., Hummel O., Rohde K., Schmidt R. E., Dominiczak A. F., Gahr M., Hollis T., Perrino F. W., Lieberman J., Hbner N., Mutations in the gene encoding the 3 ′-5 ′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus Nature Genetics 2007 39 9 1065 1067 (Pubitemid 47340647)
62. Namjou B., Kothari P. H., Kelly J. A., Glenn S. B., Ojwang J. O., Adler A., Alarcn-Riquelme M. E., Gallant C. J., Boackle S. A., Criswell L. A., Kimberly R. P., Brown E., Edberg J., Stevens A. M., Jacob C. O., Tsao B. P., Gilkeson G. S., Kamen D. L., Merrill J. T., Petri M., Goldman R. R., Vila L. M., Anaya J.-M., Niewold T. B., Martin J., Pons-Estel B. A., Sabio J. M., Callejas J. L., Vyse T. J., Bae S.-C., Perrino F. W., Freedman B. I., Scofield R. H., Moser K. L., Gaffney P. M., James J. A., Langefeld C. D., Kaufman K. M., Harley J. B., Atkinson J. P., Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort Genes and Immunity 2011 12 4 270 279
63. Sawalha A. H., Webb R., Han S., Kelly J. A., Kaufman K. M., Kimberly R. P., Alarcn-Riquelme M. E., James J. A., Vyse T. J., Gilkeson G. S., Choi C. B., Scofield R. H., Bae S. C., Nath S. K., Harley J. B., Common variants within MECP2 confer risk of systemic lupus erythematosus PLoS One 2008 3 3
64. Jacob C. O., Zhu J., Armstrong D. L., Yan M., Han J., Zhou X. J., Thomas J. A., Reiff A., Myones B. L., Ojwang J. O., Kaufman K. M., Klein-Gitelman M., McCurdy D., Wagner-Weiner L., Silverman E., Ziegler J., Kelly J. A., Merrill J. T., Harley J. B., Ramsey-Goldman R., Vila L. M., Bae S. C., Vyse T. J., Gilkeson G. S., Gaffney P. M., Moser K. L., Langefeld C. D., Zidovetzki R., Mohan C., Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus Proceedings of the National Academy of Sciences of the United States of America 2009 106 15 6256 6261
65. Webb R., Wren J. D., Jeffries M., Kelly J. A., Kaufman K. M., Tang Y., Frank M. B., Merrill J., Kimberly R. P., Edberg J. C., Ramsey-Goldman R., Petri M., Reveille J. D., Alarcn G. S., Vil L. M., Alarcn-Riquelme M. E., James J. A., Vyse T. J., Moser K. L., Gaffney P. M., Gilkeson G. S., Harley J. B., Sawalha A. H., Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus Arthritis and Rheumatism 2009 60 4 1076 1084
66. Zhou X.-J., Lu X.-L., Lv J.-C., Yang H.-Z., Qin L.-X., Zhao M.-H., Su Y., Li Z.-G., Zhang H., Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population Annals of the Rheumatic Diseases 2011 70 7 1330 1337
67. Graham R. R., Hom G., Ortmann W., Behrens T. W., Review of recent genome-wide association scans in lupus Journal of Internal Medicine 2009 265 6 680 688
68. Kawasaki A., Ito S., Furukawa H., Hayashi T., Goto D., Matsumoto I., Kusaoi M., Ohashi J., Graham R. R., Matsuta K., Behrens T. W., Tohma S., Takasaki Y., Hashimoto H., Sumida T., Tsuchiya N., Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study Arthritis Research Therapy 2010 12 5, article R174
69. Mannik M., Merrill C. E., Stamps L. D., Wener M. H., Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus Journal of Rheumatology 2003 30 7 1495 1504 (Pubitemid 36835445)
70. Nimmerjahn F., Ravetch J. V., Fc receptors: old friends and new family members Immunity 2006 24 1 19 28 (Pubitemid 43077197)
71. Yung S., Tsang R. C. W., Sun Y., Leung J. K. H., Chan T. M., Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis Journal of the American Society of Nephrology 2005 16 11 3281 3294 (Pubitemid 46179333)
72. Bolland S., Ravetch J. V., Spontaneous autoimmune disease in Fc RIIB-deficient mice results from strain-specific epistasis Immunity 2000 13 2 277 285
73. Shankland S. J., Eitner F., Hudkins K. L., Goodpaster T., D'Agati V., Alpers C. E., Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation Kidney International 2000 58 2 674 683 (Pubitemid 30620016)
74. Cervera R., Khamashta M. A., Font J., Sebastiani G. D., Gil A., Lavilla P., Domenech I., Aydintug A. O., Jedryka-Goral A., De Ramon E., Galeazzi M., Haga H.-J., Mathieu A., Houssiau F., Ingelmo M., Hughes G. R. V., Lopez-Soto A., Vivancos J., Urbano-Marquez A., Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients Medicine 1993 72 2 113 124 (Pubitemid 23097765)
75. Frger F., Matthias T., Oppermann M., Becker H., Helmke K., Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis Lupus 2004 13 1 36 44 (Pubitemid 38129349)
76. Waters S. T., McDuffie M., Bagavant H., Deshmukh U. S., Gaskin F., Jiang C., Tung K. S. K., Fu S. M., Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis Journal of Experimental Medicine 2004 199 2 255 264 (Pubitemid 38129705)
77. Matsumoto K., Watanabe N., Akikusa B., Kurasawa K., Matsumura R., Saito Y., Iwamoto I., Saito T., Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice Arthritis and Rheumatism 2003 48 2 486 494 (Pubitemid 36278018)
78. Amoura Z., Piette J. C., Bach J. F., Koutouzov S., The key role of nucleosomes in lupus Arthritis and Rheumatism 1999 42 5 833 843 (Pubitemid 29214993)
79. van Bruggen M. C. J., Kramers C., Walgreen B., Elema J. D., Kallenberg C. G. M., van Den Born J., Smeenk R. J. T., Assmann K. J. M., Muller S., Monestier M., Berden J. H. M., Nucleosomes and histones are present in glomerular deposits in human lupus nephritis Nephrology Dialysis Transplantation 1997 12 1 57 66 (Pubitemid 27046202)
80. Krishnan M. R., Marion T. N., Structural similarity of antibody variable regions from immune and autoimmune anti-DNA antibodies Journal of Immunology 1993 150 11 4948 4957 (Pubitemid 23150362)
81. Kalaaji M., Mortensen E., Jrgensen L., Olsen R., Rekvig O. P., Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells American Journal of Pathology 2006 168 6 1779 1792 (Pubitemid 43825300)
82. Kalaaji M., Fenton K. A., Mortensen E. S., Olsen R., Sturfelt G., Alm P., Rekvig O. P., Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis Kidney International 2007 71 7 664 672 (Pubitemid 46494570)
83. Trouw L. A., Groeneveld T. W. L., Seelen M. A., Duijs J. M. G. J., Bajema I. M., Prins F. A., Kishore U., Salant D. J., Verbeek J. S., van Kooten C., Daha M. R., Anti C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes The Journal of Clinical Investigation 2004 114 5 679 688 (Pubitemid 39578758)
84. Muoz L. E., Janko C., Schulze C., Schorn C., Sarter K., Schett G., Herrmann M., Autoimmunity and chronic inflammationtwo clearance-related steps in the etiopathogenesis of SLE Autoimmunity Reviews 2010 10 1 38 42
85. Segerer S., Heller F., Lindenmeyer M. T., Schmid H., Cohen C. D., Draganovici D., Mandelbaum J., Nelson P. J., Grne H. J., Grne E. F., Figel A. M., Nssner E., Schlndorff D., Compartment specific expression of dendritic cell markers in human glomerulonephritis Kidney International 2008 74 1 37 46 (Pubitemid 351841902)
86. Mevorach D., Zhou J. L., Song X., Elkon K. B., Systemic exposure to irradiated apoptotic cells induces autoantibody production Journal of Experimental Medicine 1998 188 2 387 392 (Pubitemid 28357766)
87. Munoz L. E., Gaipl U. S., Franz S., Sheriff A., Voll R. E., Kalden J. R., Herrmann M., SLEa disease of clearance deficiency? Rheumatology 2005 44 9 1101 1107
88. Kamradt T., Avrion Mitchison N., Tolerance and autoimmunity The New England Journal of Medicine 2001 344 9 655 664 (Pubitemid 32183582)
89. Franz S., Gaipl U., Appelt U., The role of a defective clearance in the pathogenesis of systemic lupus erythematosus Arthritis Research Therapy 2004 6, article 104
90. Licht R., Dieker J. W. C., Jacobs C. W. M., Tax W. J. M., Berden J. H. M., Decreased phagocytosis of apoptotic cells in diseased SLE mice Journal of Autoimmunity 2004 22 2 139 145 (Pubitemid 38252970)
91. Faurschou M., Penkowa M., Andersen C. B., Starklint H., Jacobsen S., Renal cell apoptosis in human lupus nephritis: a histological study Lupus 2009 18 11 994 999
92. Schmitt N., Morita R., Bourdery L., Bentebibel S. E., Zurawski S. M., Banchereau J., Ueno H., Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12 Immunity 2009 31 1 158 169
93. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y. J., Pulendran B., Palucka K., Immunobiology of dendritic cells Annual Review of Immunology 2000 18 767 811 (Pubitemid 30365397)
94. Kirou K. A., Lee C., George S., Louca K., Peterson M. G. E., Crow M. K., Activation of the interferon- pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease Arthritis and Rheumatism 2005 52 5 1491 1503 (Pubitemid 40663941)
95. Fiore N., Castellano G., Blasi A., Capobianco C., Loverre A., Montinaro V., Netti S., Torres D., Manno C., Grandaliano G., Ranieri E., Schena F. P., Gesualdo L., Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis Molecular Immunology 2008 45 1 259 265 (Pubitemid 47331644)
96. Woltman A. M., De Fijter J. W., Zuidwijk K., Vlug A. G., Bajema I. M., van Der Kooij S. W., van Ham V., van Kooten C., Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions Kidney International 2007 71 10 1001 1008 (Pubitemid 46741991)
97. Lewis E. J., Schwartz M. M., Korbet S. M., Mao D. T., Lupus Nephritis 2011 2nd Oxford University Press
98. Kyttaris V. C., Zhang Z., Kampagianni O., Tsokos G. C., Calcium signaling in systemic lupus erythematosus T cells: a treatment target Arthritis and Rheumatism 2011 63 7 2058 2066
99. Alexopoulos E., Seron D., Hartley R. B., Cameron J. S., Lupus nephritis: correlation of interstitial cells with glomerular function Kidney International 1990 37 1 100 109 (Pubitemid 20023773)
100. Massengill S. F., Goodenow M. M., Sleasman J. W., SLE nephritis is associated with an oligoclonal expansion of intrarenal T cells American Journal of Kidney Diseases 1998 31 3 418 426 (Pubitemid 28124095)
101. Crispn J. C., Oukka M., Bayliss G., Cohen R. A., van Beek C. A., Stillman I. E., Kyttaris V. C., Juang Y. T., Tsokos G. C., Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys Journal of Immunology 2008 181 12 8761 8766
102. Dolff S., Abdulahad W. H., van Dijk M. C. R. F., Limburg P. C., Kallenberg C. G. M., Bijl M., Urinary T cells in active lupus nephritis show an effector memory phenotype Annals of the Rheumatic Diseases 2010 69 11 2034 2041
103. Datta S. K., Major peptide autoepitopes for nucleosome-centered T and B cell interaction in human and murine lupus Annals of the New York Academy of Sciences 2003 987 79 90 (Pubitemid 36584009)
104. Peng S. L., Experimental use of murine lupus models Methods in Molecular Medicine 2004 102 227 272
105. Foster M. H., Relevance of systemic lupus erythematosus nephritis animal models to human disease Seminars in Nephrology 1999 19 1 12 24 (Pubitemid 29048842)
106. Peng S. L., Moslehi J., Craft J., Roles of interferon- and interleukin-4 in murine lupus The Journal of Clinical Investigation 1997 99 8 1936 1946 (Pubitemid 27175941)
107. Schwarting A., Wada T., Kinoshita K., Tesch G., Kelley V. R., IFN- receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice Journal of Immunology 1998 161 1 494 503 (Pubitemid 28285560)
108. Bettelli E., Carrier Y., Gao W., Korn T., Strom T. B., Oukka M., Weiner H. L., Kuchroo V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 2006 441 7090 235 238
109. Boss P., Neumann D., Del Giudice E., Ciaramella A., Gloaguen I., Fantuzzi G., Dinarello C. A., Di Carlo E., Musiani P., Meroni P. L., Caselli G., Ruggiero P., Boraschi D., IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease Proceedings of the National Academy of Sciences of the United States of America 2003 100 2 14181 14186 (Pubitemid 37499211)
110. Calvani N., Tucci M., Richards H. B., Tartaglia P., Silvestris F., Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18 Autoimmunity Reviews 2005 4 8 542 548 (Pubitemid 41415767)
111. Teramoto K., Negoro N., Kitamoto K., Iwai T., Iwao H., Okamura M., Miura K., Microarray analysis of glomerular gene expression in murine lupus nephritis Journal of Pharmacological Sciences 2008 106 1 56 67 (Pubitemid 351159069)
112. Sis A., Ramos-Casals M., Bové A., Brito-Zern P., Soria N., Nardi N., Testi A., Perez-De-Lis M., Daz-Lagares C., Darnell A., Sents J., Coca A., Outcomes in biopsy-proven lupus nephritis: evaluation of 190 white patients from a single center Medicine 2010 89 5 300 307
113. Chan R. W. Y., Lai F. M. M., Li E. K. M., Tam L. S., Chow K. M., Lai K. B., Li P. K. T., Szeto C. C., Intrarenal cytokine gene expression in lupus nephritis Annals of the Rheumatic Diseases 2007 66 7 886 892
114. Uhm W. S., Na K., Song G. W., Jung S. S., Lee T., Park M. H., Yoo D. H., Cytokine balance in kidney tissue from lupus nephritis patients Rheumatology 2003 42 8 935 938 (Pubitemid 37220958)
115. Masutani K., Akahoshi M., Tsuruya K., Tokumoto M., Ninomiya T., Kohsaka
116. Takahashi S., Fossati L., Iwamoto M., Merino R., Motta R., Kobayakawa T., Izui S., Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice The Journal of Clinical Investigation 1996 97 7 1597 1604 (Pubitemid 26105469)
117. Shimizu S., Sugiyama N., Masutani K., Sadanaga A., Miyazaki Y., Inoue Y., Akahoshi M., Katafuchi R., Hirakata H., Harada M., Hamano S., Nakashima H., Yoshida H., Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1) Journal of Immunology 2005 175 11 7185 7192 (Pubitemid 41713412)
118. Kawasaki Y., Suzuki J., Sakai N., Isome M., Nozawa R., Tanji M., Suzuki H., Evaluation of T helper-1/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritis American Journal of Kidney Diseases 2004 44 1 42 49 (Pubitemid 38880925)
119. Yamada M., Yagita H., Inoue H., Takanashi T., Matsuda H., Munechika E., Kanamaru Y., Shirato I., Tomino Y., Matushima K., Okumura K., Hashimoto H., Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis Arthritis and Rheumatism 2002 46 3 735 740 (Pubitemid 34214254)
120. Nguyen V., Cudrici C., Zernetkina V., Niculescu F., Rus H., Drachenberg C., Rus V., TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects Clinical Immunology 2009 132 1 32 42
121. Renaudineau Y., Pers J. O., Bendaoud B., Jamin C., Youinou P., Dysfunctional B cells in systemic lupus erythematosus Autoimmunity Reviews 2004 3 7-8 516 523 (Pubitemid 39531244)
122. Tsubata T., B cell abnormality and autoimmune disorders Autoimmunity 2005 38 5 331 337 (Pubitemid 41358662)
123. Dolff S., Wilde B., Patschan S., Drig J., Specker C., Philipp T., Kribben A., Witzke O., Peripheral circulating activated B-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus Scandinavian Journal of Immunology 2007 66 5 584 590 (Pubitemid 47609699)
124. Zhang H. F., Lu S., Morrison S. L., Tomlinson S., Targeting of functional antibody-decay-accelerating factor fusion proteins to a cell surface The Journal of Biological Chemistry 2001 276 29 27290 27295
125. Jacob N., Stohl W., Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future Autoimmunity 2010 43 1 84 97
126. Chang A., Henderson S. G., Brandt D., Liu N., Guttikonda R., Hsieh C., Kaverina N., Utset T. O., Meehan S. M., Quigg R. J., Meffre E., Clark M. R., In situ B Cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis Journal of Immunology 2011 186 3 1849 1860
127. Steinmetz O. M., Velden J., Kneissler U., Marx M., Klein A., Helmchen U., Stahl R. A. K., Panzer U., Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis Kidney International 2008 74 4 448 457
128. Binard A., Le Pottier L., Saraux A., Devauchelle-Pensec V., Pers J. O., Youinou P., Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus? Journal of Autoimmunity 2008 30 1-2 63 67
129. Stadanlick J. E., Cancro M. P., BAFF and the plasticity of peripheral B cell tolerance Current Opinion in Immunology 2008 20 2 158 161
130. Mackay F., Woodcock S. A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J. L., Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations Journal of Experimental Medicine 1999 190 11 1697 1710 (Pubitemid 30002351)
131. Groom J. R., Fletcher C. A., Walters S. N., Grey S. T., Watt S. V., Sweet M. J., Smyth M. J., Mackay C. R., Mackay F., BAFF and MyD88 signals promote a lupuslike disease independent of T cells Journal of Experimental Medicine 2007 204 8 1959 1971 (Pubitemid 47236330)
132. Ryan M. C., Grewal I. S., Targeting of BAFF and APRIL for autoimmunity and oncology Advances in Experimental Medicine and Biology 2009 647 52 63
133. Iikuni N., Loureno E. V., Hahn B. H., La Cava A., Cutting edge: regulatory T cells directly suppress B cells in systemic lupus erythematosus Journal of Immunology 2009 183 3 1518 1522
134. Narumi S., Takeuchi T., Kobayashi Y., Konishi K., Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus Cytokine 2000 12 10 1561 1565
135. Korn T., Bettelli E., Oukka M., Kuchroo V. K., IL-17 and Th17 cells Annual Review of Immunology 2009 27 485 517
136. Cosmi L., De Palma R., Santarlasci V., Maggi L., Capone M., Frosali F., Rodolico G., Querci V., Abbate G., Angeli R., Berrino L., Fambrini M., Caproni M., Tonelli F., Lazzeri E., Parronchi P., Liotta F., Maggi E., Romagnani S., Annunziato F., Human interleukin 17-producing cells originate from a CD161 + CD4 + T cell precursor Journal of Experimental Medicine 2008 205 8 1903 1916
137. Zhao X. F., Pan H. F., Yuan H., Zhang W. H., Li X. P., Wang G. H., Wu G. C., Su H., Pan F. M., Li W. X., Li L. H., Chen G. P., Ye D. Q., Increased serum interleukin 17 in patients with systemic lupus erythematosus Molecular Biology Reports 2010 37 1 81 85
138. Wong C. K., Lit L. C. W., Tam L. S., Li E. K. M., Wong P. T. Y., Lam C. W. K., Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity Clinical Immunology 2008 127 3 385 393
139. Gerli R., Nocentini G., Alunno A., Bocci E. B., Bianchini R., Bistoni O., Riccardi C., Identification of regulatory T cells in systemic lupus erythematosus Autoimmunity Reviews 2009 8 5 426 430
140. Crispin J. C., Martnez A., Alcocer-Varela J., Quantification of regulatory T cells in patients with systemic lupus erythematosus Journal of Autoimmunity 2003 21 3 273 276 (Pubitemid 37410115)
141. Alvarado-Snchez B., Hernndez-Castro B., Portales-Pérez D., Baranda L., Layseca-Espinosa E., Abud-Mendoza C., Cubillas-Tejeda A. C., Gonzlez-Amaro R., Regulatory T cells in patients with systemic lupus erythematosus Journal of Autoimmunity 2006 27 2 110 118 (Pubitemid 44528260)
142. Venigalla R. K. C., Tretter T., Krienke S., Max R., Eckstein V., Blank N., Fiehn C., Ho A. D., Lorenz H. M., Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127-/low regulatory T cells in patients with active systemic lupus erythematosus Arthritis and Rheumatism 2008 58 7 2120 2130 (Pubitemid 351988104)
143. Li Y., Harada T., Juang Y. T., Kyttaris V. C., Wang Y., Zidanic M., Tung K., Tsokos G. C., Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus Journal of Immunology 2007 178 3 1938 1947 (Pubitemid 46154667)
144. Wu T., Xie C., Wang H. W., Zhou X. J., Schwartz N., Calixto S., Mackay M., Aranow C., Putterman C., Mohan C., Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis Journal of Immunology 2007 179 10 7166 7175
145. D'Agati V. D., Appel G. B., Estes D., Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis Kidney International 1986 30 4 573 581 (Pubitemid 16000803)
146. Entani C., Expression of platelet-derived growth factor in Lupus nephritis in MRL/MpJ-lpr/lpr mice Nephron 1997 77 1 100 104 (Pubitemid 27395348)
147. Saxena V., Lienesch D. W., Zhou M., Bommireddy R., Azhar M., Doetschman T., Singh R. R., Dual roles of immunoregulatory cytokine TGF- in the pathogenesis of autoimmunity-mediated organ damage Journal of Immunology 2008 180 3 1903 1912
148. Segerer S., Nelson P. J., Schlndorff D., Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies Journal of the American Society of Nephrology 2000 11 1 152 176 (Pubitemid 30020438)
149. Aringer M., Smolen J. S., Cytokine expression in lupus kidneys Lupus 2005 14 1 13 18 (Pubitemid 40216062)
150. Magnusson M., Magnusson S., Vallin H., Rnnblom L., Alm G. V., Importance of CpG dinucleotides in activation of natural IFN- -producing cells by a lupus-related oligodeoxynucleotide Scandinavian Journal of Immunology 2001 54 6 543 550 (Pubitemid 34131763)
151. Gota C., Calabrese L., Induction of clinical autoimmune disease by therapeutic interferon- Autoimmunity 2003 36 8 511 518 (Pubitemid 37498247)
152. Crow M. K., Kirou K. A., Wohlgemuth J., Microarray analysis of interferon-regulated genes in SLE Autoimmunity 2003 36 8 481 490 (Pubitemid 37498244)
153. Shodell M., Shah K., Siegal F. P., Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration Lupus 2003 12 3 222 230 (Pubitemid 36458681)
154. Richards H. B., Satoh M., Shaw M., Libert C., Poli V., Reeves W. H., Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus Journal of Experimental Medicine 1998 188 5 985 990 (Pubitemid 28433425)
155. Foster M. H., T Cells and B Cells in Lupus Nephritis Seminars in Nephrology 2007 27 1 47 58
156. Calvani N., Richards H. B., Tucci M., Pannarale G., Silvestris F., Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis Clinical and Experimental Immunology 2004 138 1 171 178 (Pubitemid 39279981)
157. Li Y., Tucci M., Narain S., Barnes E. V., Sobel E. S., Segal M. S., Richards H. B., Urinary biomarkers in lupus nephritis Autoimmunity Reviews 2006 5 6 383 388 (Pubitemid 44143030)
158. Ohtsuka K., Gray J. D., Stimmler M. M., Toro B., Horwitz D. A., Decreased production of TGF- by lymphocytes from patients with systemic lupus erythematosus Journal of Immunology 1998 160 5 2539 2545 (Pubitemid 28119941)
159. Yamamoto K., Loskutoff D. J., Expression of transforming growth factor- and tumor necrosis factor- in the plasma and tissues of mice with lupus nephritis Laboratory Investigation 2000 80 10 1561 1570
160. Deocharan B., Marambio P., Edelman M., Putterman C., Differential effects of interleukin-4 in peptide induced autoimmunity Clinical Immunology 2003 108 2 80 88 (Pubitemid 36960069)
161. Nakajima A., Hirose S., Yagita H., Okumura K., Roles of IL-4 and IL-12 in the development of Lupus in NZB/W F1 mice Journal of Immunology 1997 158 3 1466 1472 (Pubitemid 127469975)
162. Hunter M. G., Hurwitz S., Bellamy C. O. C., Duffield J. S., Quantitative morphometry of lupus nephritis: the significance of collagen, tubular space, and inflammatory infiltrate Kidney International 2005 67 1 94 102 (Pubitemid 40019230)
163. Singh R. R., Saxena V., Zang S., Li L., Finkelman F. D., Witte D. P., Jacob C. O., Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis Journal of Immunology 2003 170 9 4818 4825 (Pubitemid 36519992)
164. Lit L. C. W., Wong C. K., Tam L. S., Li E. K. M., Lam C. W. K., Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus Annals of the Rheumatic Diseases 2006 65 2 209 215 (Pubitemid 43131995)
165. Viedt C., Orth S. R., Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? Nephrology Dialysis Transplantation 2002 17 12 2043 2047 (Pubitemid 35446657)
166. Alzawawy A., Zohary M., Ablordiny M., Eldalie M., Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis International Journal of Rheumatic Diseases 2009 12 4 311 318
167. Chong B. F., Mohan C., Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus Expert Opinion on Therapeutic Targets 2009 13 10 1147 1153
168. Steinmetz O. M., Turner J. E., Paust H. J., Lindner M., Peters A., Heiss K., Velden J., Hopfer H., Fehr S., Krieger T., Meyer-Schwesinger C., Meyer T. N., Helmchen U., Mittrcker H. W., Stahl R. A. K., Panzer U., CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis Journal of Immunology 2009 183 7 4693 4704
169. Enghard P., Humrich J. Y., Rudolph B., Rosenberger S., Biesen R., Kuhn A., Manz R., Hiepe F., Radbruch A., Burmester G. R., Riemekasten G., CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients Arthritis and Rheumatism 2009 60 1 199 206
170. Avihingsanon Y., Phumesin P., Benjachat T., Akkasilpa S., Kittikowit V., Praditpornsilpa K., Wongpiyabavorn J., Eiam-Ong S., Hemachudha T., Tungsanga K., Hirankarn N., Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis Kidney International 2006 69 4 747 753 (Pubitemid 43237645)
171. Pérez de Lema G., Maier H., Nieto E., Vielhauer V., Luckow B., Mampaso F., Schlondorff D., Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis Journal of the American Society of Nephrology 2001 12 7 1369 1382 (Pubitemid 32666320)
172. Furuichi K., Wada T., Sakai N., Iwata Y., Yoshimoto K., Shimizu M., Kobayashi K. I., Takasawa K., Kida H., Takeda S. I., Mukaida N., Matsushima K., Yokoyama H., Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases American Journal of Nephrology 2000 20 4 291 299
173. Gao H. X., Campbell S. R., Burkly L. C., Jakubowski A., Jarchum I., Banas B., Saleem M. A., Mathieson P. W., Berman J. W., Michaelson J. S., Putterman C., TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells Cytokine 2009 46 1 24 35
174. Schwartz N., Rubinstein T., Burkly L. C., Collins C. E., Blanco I., Su L., Hojaili B., Mackay M., Aranow C., Stohl W., Rovin B. H., Michaelson J. S., Putterman C., Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study Arthritis Research Therapy 2009 11 5, article R143
175. Weening J. J., D'Agati V. D., Schwartz M. M., Seshan S. V., Alpers C. E., Appel G. B., Balow J. E., Bruijn J. A., Cook T., Ferrario F., Fogo A. B., Ginzler E. M., Hebert L., Hill G., Hill P., Jennette J. C., Kong N. C., Lesavre P., Lockshin M., Looi L. M., Makino H., Moura L. A., Nagata M., The classification of glomerulonephritis in systemic lupus erythematosus revisited Journal of the American Society of Nephrology 2004 15 2 241 250 (Pubitemid 38140764)
176. Giannakakis K., Faraggiana T., Histopathology of lupus nephritis Clinical Reviews in Allergy and Immunology 2011 40 3 170 180
177. Park M. H., D'Agati V., Appel G. B., Pirani C. L., Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis Nephron 1986 44 4 309 319 (Pubitemid 17178104)
178. Uchida K., Nitta K., Recent advances in the treatment of lupus nephritis. Clinical and Experimental Nephrology. In press
179. Cervera R., Khamashta M. A., Font J., Sebastiani G. D., Gil A., Lavilla P., Meja J. C., Aydintug A. O., Chwalinska-Sadowska H., De Ramn E., Fernndez-Nebro A., Galeazzi M., Valen M., Mathieu A., Houssiau F., Caro N., Alba P., Ramos-Casals M., Ingelmo M., Hughes G. R. V., Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients Medicine 2003 82 5 299 308 (Pubitemid 37229465)
180. Dooley M. A., Falk R. J., Human clinical trials in Lupus nephritis Seminars in Nephrology 2007 27 1 115 127
181. Durn-barragn S., Mcgwin G. Jr., Vil L. M., Reveille J. D., Alarcn G. S., Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosusresults from LUMINA (LIX): a multiethnic US cohort Rheumatology 2008 47 7 1093 1096 (Pubitemid 351865941)
182. Gourley M. F., Austin H. A., Scott D., Yarboro C. H., Vaughan E. M., Muir J., Boumpas D. T., Klippel J. H., Balow J. E., Steinberg A. D., Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial Annals of Internal Medicine 1996 125 7 549 557 (Pubitemid 126450087)
183. Houssiau F. A., Vasconcelos C., D'Cruz D., Sebastiani G. D., De Ramon Garrido E., Danieli M. G., Abramovicz D., Blockmans D., Mathieu A., Direskeneli H., Galeazzi M., Gl A., Levy Y., Petera P., Popovic R., Petrovic R., Sinico R. A., Cattaneo R., Font J., Depresseux G., Cosyns J. P., Cervera R., Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide Arthritis and Rheumatism 2002 46 8 2121 2131
184. Houssiau F. A., Vasconcelos C., D'Cruz D., Sebastiani G. D., De Ramon Garrido E., Danieli M. G., Abramovicz D., Blockmans D., Cauli A., Direskeneli H., Galeazzi M., Gl A., Levy Y., Petera P., Popovic R., Petrovic R., Sinico R. A., Cattaneo R., Font J., Depresseux G., Cosyns J. P., Cervera R., The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide Annals of the Rheumatic Diseases 2010 69 1 61 64
185. Chan T. M., Li F. K., Tang C. S. O., Wong R. W. S., Fang G. X., Ji Y. L., Lau C. S., Wong A. K. M., Tong M. K. L., Chan K. W., Lai K. N., Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis The New England Journal of Medicine 2000 343 16 1156 1162
186. Appel G. B., Contreras G., Dooley M. A., Ginzler E. M., Isenberg D., Jayne D., Li L. S., Mysler E., Snchez-Guerrero J., Solomons N., Wofsy D., Abud C., Adler S., Alarcn G., Albuquerque E., Almeida F., Alvarellos A., Appel G., Avila H., Blume C., Boletis I., Bonnardeaux A., Braun A., Buyon J., Cervera R., Chen N., Chen S., Da Costa A. G., Davids R., D'Cruz D., De Ramn E., Deodhar A., Doria A., Dussol B., Emery P., Fiechtner J., Floege J., Fragoso-Loyo H., Furie R., Ghazalli R., Ghossein C., Gilkeson G., Ginzler E., Gordon C., Grossman J., Gu J., Guillevin L., Hatron P. Y., Herrera G., Hiepe F., Houssiau F., Hbscher O., Hura C., Kaplan J., Kirsztajn G., Kiss E., Kutty G. A., Laville M., Lazaro M., Lenz O., Li L., Lightstone L., Lim S., Malaise M., Manzi S., Marcos J., Meyer O., Monge P., Naicker S., Neal N., Neuwelt M., Nicholls K., Olsen N., Ordi-Ros J., Ostrov B., Pestana M., Petri M., Pokorny G., Pourrat J., Qian J., Radhakrishnan J., Rovin B., Roman J. S., Shanahan J., Shergy W., Skopouli F., Spindler A., Striebich C., Sundel R., Swanepoel C., Si Y. T., Tate G., Tesa V., Tikly M., Wang H., Yahya R., Yu X., Zhang F., Zoruba D., Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis Journal of the American Society of Nephrology 2009 20 5 1103 1112
187. Miyasaka N., Kawai S., Hashimoto H., Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study Modern Rheumatology 2009 19 6 606 615
188. Szeto C. C., Kwan B. C. H., Lai F. M. M., Tam L. S., Li E. K. M., Chow K. M., Gang W., Li P. K. T., Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis Rheumatology 2008 47 11 1678 1681
189. Mok C. C., Tong K. H., To C. H., Siu Y. P., Au T. C., Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study Kidney International 2005 68 2 813 817 (Pubitemid 43323138)
190. Asamiya Y., Uchida K., Otsubo S., Takei T., Nitta K., Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center NephronClinical Practice 2009 113 4 c330 c336
191. Uchida K., Asamiya Y., Takei T., Itabashi M., Sugiura H., Tsukada M., Nitta K., Pharmacokinetics of orally administered tacrolimus in lupus nephritis patients Yakugaku Zasshi 2010 130 1 113 118
192. Tanaka H., Oki E., Tsuruga K., Yashiro T., Hanada I., Ito E., Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose Clinical Nephrology 2009 72 6 430 436
193. Uchino A., Tsukamoto H., Nakashima H., Tacrolimus is effective for lupus nephritis patients with persistent proteinuria Clinical and Experimental Rheumatology 2010 28 6 12
194. Houssiau F. A., D'Cruz D., Sangle S., Remy P., Vasconcelos C., Petrovic R., Fiehn C., Garrido E. D. R., Gilboe I. M., Tektonidou M., Blockmans D., Ravelingien I., Le Guern V., Depresseux G., Guillevin L., Cervera R., Abramowicz D., Atzeni F., Danieli M. G., De Clercq L., De Keyser F., Delahousse M., Espinosa G., Golstein M., Hirsch M., Karras A., Lang P., Marchal M., Marinho A., Max R., Peeters P., Petera P., Quémeneur T., Raeman F., Sarzi-Puttini P., De Santis L. V., Verresen L., Weiss L., Westhovens R., Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial Annals of the Rheumatic Diseases 2010 69 12 2083 2089
195. Flanc R. S., Roberts M. A., Strippoli G. F., Chadban S. J., Kerr P. G., Atkins R. C., Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials American Journal of Kidney Diseases 2004 43 2 197 208
196. Zhu B., Chen N., Lin Y., Ren H., Zhang W., Wang W. M., Pan X. X., Yu H. J., Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials Nephrology Dialysis Transplantation 2007 22 7 1933 1942 (Pubitemid 47244763)
197. Lee Y. H., Woo J. H., Choi S. J., Ji J. D., Song G. G., Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis Lupus 2010 19 6 703 710
198. Catapano F., Chaudhry A. N., Jones R. B., Smith K. G., Jayne D. W., Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus Nephrology, Dialysis, Transplantation 2010 25 11 3586 3592
199. Ramos-Casals M., Soto M. J., Cuadrado M. J., Khamashta M. A., Rituximab in systemic lupus erythematosus A systematic review of off-label use in 188 cases Lupus 2009 18 9 767 776